Axial Spondyloarthritis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027

Table of Content

1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Axial Spondyloarthritis Treatment Market
5. Voice of Customer
6. Clinical Trial Analysis
7. Global Axial Spondyloarthritis Treatment Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Therapy (Anti-Tumor Necrosis Factor (TNF) Therapy, Anti-Interleukin (IL) Therapy, Anti-Janus Kinase (JAK) Therapy)
7.2.2. By Indication (Ankylosing Spondylitis v/s Non-radiographic Axial Spondyloarthritis Treatment)
7.2.3. By End User (Hospitals & Clinics, Academic & Research Institutions, Others)
7.2.4. By Region
7.2.5. By Company (2021)
7.3. Market Map
8. North America Axial Spondyloarthritis Treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Therapy
8.2.2. By Indication
8.2.3. By End User
8.2.4. By Country
8.3. North America: Country Analysis
8.3.1. United States Axial Spondyloarthritis Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Therapy
8.3.1.2.2. By Indication
8.3.1.2.3. By End User
8.3.2. Canada Axial Spondyloarthritis Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Therapy
8.3.2.2.2. By Indication
8.3.2.2.3. By End User
8.3.3. Mexico Axial Spondyloarthritis Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Therapy
8.3.3.2.2. By Indication
8.3.3.2.3. By End User
9. Europe Axial Spondyloarthritis Treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Therapy
9.2.2. By Indication
9.2.3. By End User
9.2.4. By Country
9.3. Europe: Country Analysis
9.3.1. France Axial Spondyloarthritis Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Therapy
9.3.1.2.2. By Indication
9.3.1.2.3. By End User
9.3.2. Germany Axial Spondyloarthritis Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Therapy
9.3.2.2.2. By Indication
9.3.2.2.3. By End User
9.3.3. United Kingdom Axial Spondyloarthritis Treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Therapy
9.3.3.2.2. By Indication
9.3.3.2.3. By End User
9.3.4. Italy Axial Spondyloarthritis Treatment Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Therapy
9.3.4.2.2. By Indication
9.3.4.2.3. By End User
9.3.5. Spain Axial Spondyloarthritis Treatment Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Therapy
9.3.5.2.2. By Indication
9.3.5.2.3. By End User
10. Asia-Pacific Axial Spondyloarthritis Treatment Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Therapy
10.2.2. By Indication
10.2.3. By End User
10.2.4. By Country
10.3. Asia-Pacific: Country Analysis
10.3.1. China Axial Spondyloarthritis Treatment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Therapy
10.3.1.2.2. By Indication
10.3.1.2.3. By End User
10.3.2. India Axial Spondyloarthritis Treatment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Therapy
10.3.2.2.2. By Indication
10.3.2.2.3. By End User
10.3.3. Japan Axial Spondyloarthritis Treatment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Therapy
10.3.3.2.2. By Indication
10.3.3.2.3. By End User
10.3.4. South Korea Axial Spondyloarthritis Treatment Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Therapy
10.3.4.2.2. By Indication
10.3.4.2.3. By End User
10.3.5. Australia Axial Spondyloarthritis Treatment Market Outlook
10.3.5.1. Market Size & Forecast
10.3.5.1.1. By Value
10.3.5.2. Market Share & Forecast
10.3.5.2.1. By Therapy
10.3.5.2.2. By Indication
10.3.5.2.3. By End User
11. South America Axial Spondyloarthritis Treatment Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Therapy
11.2.2. By Indication
11.2.3. By End User
11.2.4. By Country
11.3. South America: Country Analysis
11.3.1. Brazil Axial Spondyloarthritis Treatment Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Therapy
11.3.1.2.2. By Indication
11.3.1.2.3. By End User
11.3.2. Argentina Axial Spondyloarthritis Treatment Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Therapy
11.3.2.2.2. By Indication
11.3.2.2.3. By End User
11.3.3. Colombia Axial Spondyloarthritis Treatment Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Therapy
11.3.3.2.2. By Indication
11.3.3.2.3. By End User
12. Middle East and Africa Axial Spondyloarthritis Treatment Market Outlook
12.1. Market Size & Forecast
12.1.1. By Value
12.2. Market Share & Forecast
12.2.1. By Therapy
12.2.2. By Indication
12.2.3. By End User
12.2.4. By Country
12.3. MEA: Country Analysis
12.3.1. South Africa Axial Spondyloarthritis Treatment Market Outlook
12.3.1.1. Market Size & Forecast
12.3.1.1.1. By Value
12.3.1.2. Market Share & Forecast
12.3.1.2.1. By Therapy
12.3.1.2.2. By Indication
12.3.1.2.3. By End User
12.3.2. Saudi Arabia Axial Spondyloarthritis Treatment Market Outlook
12.3.2.1. Market Size & Forecast
12.3.2.1.1. By Value
12.3.2.2. Market Share & Forecast
12.3.2.2.1. By Therapy
12.3.2.2.2. By Indication
12.3.2.2.3. By End User
12.3.3. UAE Axial Spondyloarthritis Treatment Market Outlook
12.3.3.1. Market Size & Forecast
12.3.3.1.1. By Value
12.3.3.2. Market Share & Forecast
12.3.3.2.1. By Therapy
12.3.3.2.2. By Indication
12.3.3.2.3. By End User
13. Market Dynamics
13.1. Drivers
13.2. Challenges
14. Market Trends & Developments
15. Competitive Landscape (Inclusive SWOT Analysis)
15.1. Novartis International, AG
15.2. Eli Lilly and Company
15.3. Johnson & Johnson
15.4. UCB S.A.
15.5. Pfizer, Inc.
15.6. Kyowa Kirin Co., Ltd.
15.7. Merck & Co., Inc.
15.8. AbbVie Inc
15.9. Bristol-Myers Squibb Company
15.10. FunPep Co., Ltd.
16. Strategic Recommendations